nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ankylosing spondylitis—psoriatic arthritis	0.257	0.377	CtDrD
Methotrexate—rheumatoid arthritis—psoriatic arthritis	0.232	0.339	CtDrD
Methotrexate—psoriasis—psoriatic arthritis	0.194	0.284	CtDrD
Methotrexate—ALB—Auranofin—psoriatic arthritis	0.0434	0.223	CbGbCtD
Methotrexate—SLCO1A2—Prednisolone—psoriatic arthritis	0.0283	0.146	CbGbCtD
Methotrexate—SLCO1A2—Prednisone—psoriatic arthritis	0.0267	0.138	CbGbCtD
Methotrexate—SLCO1A2—Dexamethasone—psoriatic arthritis	0.0167	0.0859	CbGbCtD
Methotrexate—ABCC2—Dexamethasone—psoriatic arthritis	0.0138	0.0712	CbGbCtD
Methotrexate—ALB—Prednisone—psoriatic arthritis	0.0138	0.0711	CbGbCtD
Methotrexate—ABCG2—Dexamethasone—psoriatic arthritis	0.0125	0.0644	CbGbCtD
Methotrexate—ABCB1—Methylprednisolone—psoriatic arthritis	0.0119	0.0614	CbGbCtD
Methotrexate—ABCB1—Betamethasone—psoriatic arthritis	0.00775	0.0399	CbGbCtD
Methotrexate—ABCB1—Prednisolone—psoriatic arthritis	0.00765	0.0394	CbGbCtD
Methotrexate—ABCB1—Prednisone—psoriatic arthritis	0.00723	0.0372	CbGbCtD
Methotrexate—ATIC—pes—psoriatic arthritis	0.00546	0.464	CbGeAlD
Methotrexate—ABCB1—Dexamethasone—psoriatic arthritis	0.00451	0.0232	CbGbCtD
Methotrexate—GGH—skin of body—psoriatic arthritis	0.000647	0.0549	CbGeAlD
Methotrexate—FPGS—skin of body—psoriatic arthritis	0.000568	0.0482	CbGeAlD
Methotrexate—ATIC—skin of body—psoriatic arthritis	0.00055	0.0466	CbGeAlD
Methotrexate—SLC46A1—tendon—psoriatic arthritis	0.0005	0.0424	CbGeAlD
Methotrexate—GGH—tendon—psoriatic arthritis	0.000492	0.0418	CbGeAlD
Methotrexate—FPGS—tendon—psoriatic arthritis	0.000433	0.0367	CbGeAlD
Methotrexate—TYMS—skin of body—psoriatic arthritis	0.000373	0.0316	CbGeAlD
Methotrexate—PGD—skin of body—psoriatic arthritis	0.000355	0.0301	CbGeAlD
Methotrexate—SLCO3A1—tendon—psoriatic arthritis	0.000306	0.026	CbGeAlD
Methotrexate—TYMS—tendon—psoriatic arthritis	0.000284	0.0241	CbGeAlD
Methotrexate—DHFR—tendon—psoriatic arthritis	0.000281	0.0238	CbGeAlD
Methotrexate—PGD—tendon—psoriatic arthritis	0.00027	0.0229	CbGeAlD
Methotrexate—SLC16A1—tendon—psoriatic arthritis	0.000252	0.0214	CbGeAlD
Methotrexate—AOX1—tendon—psoriatic arthritis	0.000238	0.0202	CbGeAlD
Methotrexate—ABCC10—tendon—psoriatic arthritis	0.000232	0.0197	CbGeAlD
Methotrexate—ABCC4—tendon—psoriatic arthritis	0.000192	0.0163	CbGeAlD
Methotrexate—ABCC2—tendon—psoriatic arthritis	0.000186	0.0158	CbGeAlD
Methotrexate—ABCC1—tendon—psoriatic arthritis	0.000164	0.0139	CbGeAlD
Methotrexate—Conjunctivitis—Prednisolone—psoriatic arthritis	0.000106	0.000983	CcSEcCtD
Methotrexate—Lethargy—Prednisone—psoriatic arthritis	0.000105	0.000973	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.000105	0.000969	CcSEcCtD
Methotrexate—Osteoarthritis—Prednisone—psoriatic arthritis	0.000103	0.000954	CcSEcCtD
Methotrexate—Infestation—Methylprednisolone—psoriatic arthritis	0.0001	0.000928	CcSEcCtD
Methotrexate—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.0001	0.000928	CcSEcCtD
Methotrexate—Haemoglobin—Prednisolone—psoriatic arthritis	9.84e-05	0.000912	CcSEcCtD
Methotrexate—Irritability—Prednisone—psoriatic arthritis	9.82e-05	0.00091	CcSEcCtD
Methotrexate—Haemorrhage—Prednisolone—psoriatic arthritis	9.79e-05	0.000908	CcSEcCtD
Methotrexate—Conjunctivitis—Triamcinolone—psoriatic arthritis	9.75e-05	0.000904	CcSEcCtD
Methotrexate—Mood swings—Prednisone—psoriatic arthritis	9.74e-05	0.000903	CcSEcCtD
Methotrexate—Sweating—Methylprednisolone—psoriatic arthritis	9.6e-05	0.000889	CcSEcCtD
Methotrexate—Epistaxis—Triamcinolone—psoriatic arthritis	9.46e-05	0.000877	CcSEcCtD
Methotrexate—Visual impairment—Prednisolone—psoriatic arthritis	9.44e-05	0.000875	CcSEcCtD
Methotrexate—Haemoglobin—Triamcinolone—psoriatic arthritis	9.05e-05	0.000839	CcSEcCtD
Methotrexate—Haemoglobin—Methylprednisolone—psoriatic arthritis	9.03e-05	0.000837	CcSEcCtD
Methotrexate—Haemorrhage—Triamcinolone—psoriatic arthritis	9.01e-05	0.000835	CcSEcCtD
Methotrexate—Haemorrhage—Methylprednisolone—psoriatic arthritis	8.99e-05	0.000833	CcSEcCtD
Methotrexate—Pharyngitis—Triamcinolone—psoriatic arthritis	8.94e-05	0.000829	CcSEcCtD
Methotrexate—Conjunctivitis—Betamethasone—psoriatic arthritis	8.85e-05	0.00082	CcSEcCtD
Methotrexate—Conjunctivitis—Dexamethasone—psoriatic arthritis	8.85e-05	0.00082	CcSEcCtD
Methotrexate—Pancreatitis—Prednisone—psoriatic arthritis	8.72e-05	0.000808	CcSEcCtD
Methotrexate—Visual impairment—Methylprednisolone—psoriatic arthritis	8.66e-05	0.000803	CcSEcCtD
Methotrexate—Erythema—Prednisolone—psoriatic arthritis	8.52e-05	0.00079	CcSEcCtD
Methotrexate—Eye disorder—Methylprednisolone—psoriatic arthritis	8.4e-05	0.000778	CcSEcCtD
Methotrexate—Cardiac disorder—Methylprednisolone—psoriatic arthritis	8.34e-05	0.000773	CcSEcCtD
Methotrexate—Neutropenia—Prednisone—psoriatic arthritis	8.31e-05	0.000771	CcSEcCtD
Methotrexate—Haemoglobin—Dexamethasone—psoriatic arthritis	8.21e-05	0.000761	CcSEcCtD
Methotrexate—Haemoglobin—Betamethasone—psoriatic arthritis	8.21e-05	0.000761	CcSEcCtD
Methotrexate—Erectile dysfunction—Prednisone—psoriatic arthritis	8.19e-05	0.000759	CcSEcCtD
Methotrexate—Haemorrhage—Betamethasone—psoriatic arthritis	8.17e-05	0.000757	CcSEcCtD
Methotrexate—Haemorrhage—Dexamethasone—psoriatic arthritis	8.17e-05	0.000757	CcSEcCtD
Methotrexate—Angiopathy—Methylprednisolone—psoriatic arthritis	8.15e-05	0.000756	CcSEcCtD
Methotrexate—Immune system disorder—Methylprednisolone—psoriatic arthritis	8.12e-05	0.000752	CcSEcCtD
Methotrexate—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	8.1e-05	0.000751	CcSEcCtD
Methotrexate—Vision blurred—Prednisolone—psoriatic arthritis	8.03e-05	0.000745	CcSEcCtD
Methotrexate—Ill-defined disorder—Prednisolone—psoriatic arthritis	7.91e-05	0.000733	CcSEcCtD
Methotrexate—Depression—Prednisone—psoriatic arthritis	7.9e-05	0.000733	CcSEcCtD
Methotrexate—Visual impairment—Betamethasone—psoriatic arthritis	7.87e-05	0.00073	CcSEcCtD
Methotrexate—Visual impairment—Dexamethasone—psoriatic arthritis	7.87e-05	0.00073	CcSEcCtD
Methotrexate—Mental disorder—Methylprednisolone—psoriatic arthritis	7.87e-05	0.00073	CcSEcCtD
Methotrexate—Erythema—Triamcinolone—psoriatic arthritis	7.84e-05	0.000727	CcSEcCtD
Methotrexate—Erythema—Methylprednisolone—psoriatic arthritis	7.82e-05	0.000725	CcSEcCtD
Methotrexate—Malnutrition—Methylprednisolone—psoriatic arthritis	7.82e-05	0.000725	CcSEcCtD
Methotrexate—Malaise—Prednisolone—psoriatic arthritis	7.69e-05	0.000713	CcSEcCtD
Methotrexate—Dysgeusia—Triamcinolone—psoriatic arthritis	7.68e-05	0.000712	CcSEcCtD
Methotrexate—Vertigo—Prednisolone—psoriatic arthritis	7.66e-05	0.00071	CcSEcCtD
Methotrexate—Eye disorder—Dexamethasone—psoriatic arthritis	7.64e-05	0.000708	CcSEcCtD
Methotrexate—Eye disorder—Betamethasone—psoriatic arthritis	7.64e-05	0.000708	CcSEcCtD
Methotrexate—Back pain—Triamcinolone—psoriatic arthritis	7.58e-05	0.000703	CcSEcCtD
Methotrexate—Angiopathy—Dexamethasone—psoriatic arthritis	7.41e-05	0.000687	CcSEcCtD
Methotrexate—Angiopathy—Betamethasone—psoriatic arthritis	7.41e-05	0.000687	CcSEcCtD
Methotrexate—Convulsion—Prednisolone—psoriatic arthritis	7.39e-05	0.000685	CcSEcCtD
Methotrexate—Ill-defined disorder—Triamcinolone—psoriatic arthritis	7.27e-05	0.000674	CcSEcCtD
Methotrexate—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	7.26e-05	0.000673	CcSEcCtD
Methotrexate—Alopecia—Dexamethasone—psoriatic arthritis	7.22e-05	0.000669	CcSEcCtD
Methotrexate—Alopecia—Betamethasone—psoriatic arthritis	7.22e-05	0.000669	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Methylprednisolone—psoriatic arthritis	7.19e-05	0.0331	CbGdCrCtD
Methotrexate—Discomfort—Prednisolone—psoriatic arthritis	7.17e-05	0.000665	CcSEcCtD
Methotrexate—Haemoglobin—Prednisone—psoriatic arthritis	7.15e-05	0.000663	CcSEcCtD
Methotrexate—Haemorrhage—Prednisone—psoriatic arthritis	7.12e-05	0.00066	CcSEcCtD
Methotrexate—Erythema—Betamethasone—psoriatic arthritis	7.11e-05	0.000659	CcSEcCtD
Methotrexate—Erythema—Dexamethasone—psoriatic arthritis	7.11e-05	0.000659	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Methylprednisolone—psoriatic arthritis	7.09e-05	0.0327	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Betamethasone—psoriatic arthritis	7.07e-05	0.0326	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Dexamethasone—psoriatic arthritis	7.07e-05	0.0326	CbGdCrCtD
Methotrexate—Malaise—Triamcinolone—psoriatic arthritis	7.07e-05	0.000655	CcSEcCtD
Methotrexate—Malaise—Methylprednisolone—psoriatic arthritis	7.05e-05	0.000654	CcSEcCtD
Methotrexate—Vertigo—Triamcinolone—psoriatic arthritis	7.04e-05	0.000653	CcSEcCtD
Methotrexate—Vertigo—Methylprednisolone—psoriatic arthritis	7.03e-05	0.000651	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Methylprednisolone—psoriatic arthritis	7.02e-05	0.0324	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Betamethasone—psoriatic arthritis	6.98e-05	0.0322	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Dexamethasone—psoriatic arthritis	6.98e-05	0.0322	CbGdCrCtD
Methotrexate—Anaphylactic shock—Prednisolone—psoriatic arthritis	6.96e-05	0.000645	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Triamcinolone—psoriatic arthritis	6.91e-05	0.0319	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Betamethasone—psoriatic arthritis	6.91e-05	0.0319	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Dexamethasone—psoriatic arthritis	6.91e-05	0.0319	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	6.85e-05	0.0316	CbGdCrCtD
Methotrexate—Cough—Triamcinolone—psoriatic arthritis	6.84e-05	0.000634	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Triamcinolone—psoriatic arthritis	6.82e-05	0.0315	CbGdCrCtD
Methotrexate—Convulsion—Triamcinolone—psoriatic arthritis	6.79e-05	0.00063	CcSEcCtD
Methotrexate—Convulsion—Methylprednisolone—psoriatic arthritis	6.78e-05	0.000628	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	6.74e-05	0.0311	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Betamethasone—psoriatic arthritis	6.74e-05	0.0311	CbGdCrCtD
Methotrexate—Hyperhidrosis—Prednisolone—psoriatic arthritis	6.73e-05	0.000623	CcSEcCtD
Methotrexate—Myalgia—Triamcinolone—psoriatic arthritis	6.67e-05	0.000619	CcSEcCtD
Methotrexate—Myalgia—Methylprednisolone—psoriatic arthritis	6.66e-05	0.000617	CcSEcCtD
Methotrexate—Arthralgia—Methylprednisolone—psoriatic arthritis	6.66e-05	0.000617	CcSEcCtD
Methotrexate—Eye disorder—Prednisone—psoriatic arthritis	6.65e-05	0.000616	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	6.61e-05	0.000613	CcSEcCtD
Methotrexate—Ill-defined disorder—Betamethasone—psoriatic arthritis	6.6e-05	0.000612	CcSEcCtD
Methotrexate—Ill-defined disorder—Dexamethasone—psoriatic arthritis	6.6e-05	0.000612	CcSEcCtD
Methotrexate—Discomfort—Triamcinolone—psoriatic arthritis	6.59e-05	0.000611	CcSEcCtD
Methotrexate—TYMS—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	6.58e-05	0.0304	CbGdCrCtD
Methotrexate—Discomfort—Methylprednisolone—psoriatic arthritis	6.58e-05	0.00061	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisone—psoriatic arthritis	6.56e-05	0.0303	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Prednisone—psoriatic arthritis	6.47e-05	0.0299	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Methylprednisolone—psoriatic arthritis	6.47e-05	0.0298	CbGdCrCtD
Methotrexate—Angiopathy—Prednisone—psoriatic arthritis	6.46e-05	0.000598	CcSEcCtD
Methotrexate—Confusional state—Methylprednisolone—psoriatic arthritis	6.44e-05	0.000597	CcSEcCtD
Methotrexate—Immune system disorder—Prednisone—psoriatic arthritis	6.43e-05	0.000596	CcSEcCtD
Methotrexate—Malaise—Betamethasone—psoriatic arthritis	6.41e-05	0.000595	CcSEcCtD
Methotrexate—Malaise—Dexamethasone—psoriatic arthritis	6.41e-05	0.000595	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisone—psoriatic arthritis	6.41e-05	0.0296	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisolone—psoriatic arthritis	6.4e-05	0.0295	CbGdCrCtD
Methotrexate—Anaphylactic shock—Triamcinolone—psoriatic arthritis	6.4e-05	0.000593	CcSEcCtD
Methotrexate—Vertigo—Dexamethasone—psoriatic arthritis	6.39e-05	0.000592	CcSEcCtD
Methotrexate—Vertigo—Betamethasone—psoriatic arthritis	6.39e-05	0.000592	CcSEcCtD
Methotrexate—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	6.38e-05	0.000592	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Betamethasone—psoriatic arthritis	6.37e-05	0.0294	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Dexamethasone—psoriatic arthritis	6.37e-05	0.0294	CbGdCrCtD
Methotrexate—Infection—Triamcinolone—psoriatic arthritis	6.36e-05	0.000589	CcSEcCtD
Methotrexate—Infection—Methylprednisolone—psoriatic arthritis	6.34e-05	0.000588	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Prednisolone—psoriatic arthritis	6.32e-05	0.0291	CbGdCrCtD
Methotrexate—Insomnia—Prednisolone—psoriatic arthritis	6.29e-05	0.000583	CcSEcCtD
Methotrexate—Alopecia—Prednisone—psoriatic arthritis	6.29e-05	0.000583	CcSEcCtD
Methotrexate—Nervous system disorder—Methylprednisolone—psoriatic arthritis	6.26e-05	0.00058	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisolone—psoriatic arthritis	6.25e-05	0.0288	CbGdCrCtD
Methotrexate—Paraesthesia—Prednisolone—psoriatic arthritis	6.25e-05	0.000579	CcSEcCtD
Methotrexate—Mental disorder—Prednisone—psoriatic arthritis	6.23e-05	0.000578	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Triamcinolone—psoriatic arthritis	6.22e-05	0.0287	CbGdCrCtD
Methotrexate—Skin disorder—Methylprednisolone—psoriatic arthritis	6.2e-05	0.000575	CcSEcCtD
Methotrexate—Malnutrition—Prednisone—psoriatic arthritis	6.19e-05	0.000574	CcSEcCtD
Methotrexate—Erythema—Prednisone—psoriatic arthritis	6.19e-05	0.000574	CcSEcCtD
Methotrexate—Hyperhidrosis—Triamcinolone—psoriatic arthritis	6.19e-05	0.000573	CcSEcCtD
Methotrexate—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	6.17e-05	0.000572	CcSEcCtD
Methotrexate—Convulsion—Dexamethasone—psoriatic arthritis	6.16e-05	0.000571	CcSEcCtD
Methotrexate—Convulsion—Betamethasone—psoriatic arthritis	6.16e-05	0.000571	CcSEcCtD
Methotrexate—Myalgia—Betamethasone—psoriatic arthritis	6.06e-05	0.000561	CcSEcCtD
Methotrexate—Myalgia—Dexamethasone—psoriatic arthritis	6.06e-05	0.000561	CcSEcCtD
Methotrexate—Discomfort—Betamethasone—psoriatic arthritis	5.98e-05	0.000555	CcSEcCtD
Methotrexate—Discomfort—Dexamethasone—psoriatic arthritis	5.98e-05	0.000555	CcSEcCtD
Methotrexate—Hypotension—Methylprednisolone—psoriatic arthritis	5.97e-05	0.000553	CcSEcCtD
Methotrexate—Pain—Prednisolone—psoriatic arthritis	5.95e-05	0.000551	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisone—psoriatic arthritis	5.91e-05	0.0272	CbGdCrCtD
Methotrexate—Vision blurred—Prednisone—psoriatic arthritis	5.84e-05	0.000541	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	5.83e-05	0.00054	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	5.82e-05	0.000539	CcSEcCtD
Methotrexate—Anaphylactic shock—Betamethasone—psoriatic arthritis	5.81e-05	0.000538	CcSEcCtD
Methotrexate—Anaphylactic shock—Dexamethasone—psoriatic arthritis	5.81e-05	0.000538	CcSEcCtD
Methotrexate—Insomnia—Triamcinolone—psoriatic arthritis	5.79e-05	0.000536	CcSEcCtD
Methotrexate—Insomnia—Methylprednisolone—psoriatic arthritis	5.77e-05	0.000535	CcSEcCtD
Methotrexate—Infection—Dexamethasone—psoriatic arthritis	5.77e-05	0.000535	CcSEcCtD
Methotrexate—Infection—Betamethasone—psoriatic arthritis	5.77e-05	0.000535	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisolone—psoriatic arthritis	5.76e-05	0.0266	CbGdCrCtD
Methotrexate—Ill-defined disorder—Prednisone—psoriatic arthritis	5.75e-05	0.000533	CcSEcCtD
Methotrexate—Paraesthesia—Triamcinolone—psoriatic arthritis	5.75e-05	0.000533	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisolone—psoriatic arthritis	5.73e-05	0.000531	CcSEcCtD
Methotrexate—Paraesthesia—Methylprednisolone—psoriatic arthritis	5.73e-05	0.000531	CcSEcCtD
Methotrexate—Anaemia—Prednisone—psoriatic arthritis	5.73e-05	0.000531	CcSEcCtD
Methotrexate—Dyspnoea—Triamcinolone—psoriatic arthritis	5.7e-05	0.000529	CcSEcCtD
Methotrexate—Nervous system disorder—Betamethasone—psoriatic arthritis	5.69e-05	0.000528	CcSEcCtD
Methotrexate—Nervous system disorder—Dexamethasone—psoriatic arthritis	5.69e-05	0.000528	CcSEcCtD
Methotrexate—Thrombocytopenia—Betamethasone—psoriatic arthritis	5.68e-05	0.000527	CcSEcCtD
Methotrexate—Thrombocytopenia—Dexamethasone—psoriatic arthritis	5.68e-05	0.000527	CcSEcCtD
Methotrexate—TYMS—Budesonide—Methylprednisolone—psoriatic arthritis	5.67e-05	0.0262	CbGdCrCtD
Methotrexate—Dyspepsia—Triamcinolone—psoriatic arthritis	5.63e-05	0.000522	CcSEcCtD
Methotrexate—Dyspepsia—Methylprednisolone—psoriatic arthritis	5.62e-05	0.000521	CcSEcCtD
Methotrexate—Hyperhidrosis—Dexamethasone—psoriatic arthritis	5.61e-05	0.00052	CcSEcCtD
Methotrexate—Hyperhidrosis—Betamethasone—psoriatic arthritis	5.61e-05	0.00052	CcSEcCtD
Methotrexate—Malaise—Prednisone—psoriatic arthritis	5.59e-05	0.000518	CcSEcCtD
Methotrexate—TYMS—Budesonide—Betamethasone—psoriatic arthritis	5.58e-05	0.0258	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Dexamethasone—psoriatic arthritis	5.58e-05	0.0258	CbGdCrCtD
Methotrexate—Vertigo—Prednisone—psoriatic arthritis	5.57e-05	0.000516	CcSEcCtD
Methotrexate—Anorexia—Betamethasone—psoriatic arthritis	5.53e-05	0.000513	CcSEcCtD
Methotrexate—Anorexia—Dexamethasone—psoriatic arthritis	5.53e-05	0.000513	CcSEcCtD
Methotrexate—Urticaria—Prednisolone—psoriatic arthritis	5.53e-05	0.000512	CcSEcCtD
Methotrexate—Fatigue—Triamcinolone—psoriatic arthritis	5.52e-05	0.000511	CcSEcCtD
Methotrexate—Fatigue—Methylprednisolone—psoriatic arthritis	5.5e-05	0.00051	CcSEcCtD
Methotrexate—Pain—Triamcinolone—psoriatic arthritis	5.47e-05	0.000507	CcSEcCtD
Methotrexate—TYMS—Budesonide—Triamcinolone—psoriatic arthritis	5.46e-05	0.0252	CbGdCrCtD
Methotrexate—Hypotension—Dexamethasone—psoriatic arthritis	5.42e-05	0.000503	CcSEcCtD
Methotrexate—Hypotension—Betamethasone—psoriatic arthritis	5.42e-05	0.000503	CcSEcCtD
Methotrexate—Convulsion—Prednisone—psoriatic arthritis	5.37e-05	0.000498	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	5.29e-05	0.00049	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	5.29e-05	0.00049	CcSEcCtD
Methotrexate—Arthralgia—Prednisone—psoriatic arthritis	5.27e-05	0.000489	CcSEcCtD
Methotrexate—Myalgia—Prednisone—psoriatic arthritis	5.27e-05	0.000489	CcSEcCtD
Methotrexate—Feeling abnormal—Triamcinolone—psoriatic arthritis	5.27e-05	0.000489	CcSEcCtD
Methotrexate—Feeling abnormal—Methylprednisolone—psoriatic arthritis	5.26e-05	0.000488	CcSEcCtD
Methotrexate—Insomnia—Betamethasone—psoriatic arthritis	5.25e-05	0.000487	CcSEcCtD
Methotrexate—Insomnia—Dexamethasone—psoriatic arthritis	5.25e-05	0.000487	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	5.24e-05	0.000485	CcSEcCtD
Methotrexate—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	5.22e-05	0.000484	CcSEcCtD
Methotrexate—Paraesthesia—Dexamethasone—psoriatic arthritis	5.21e-05	0.000483	CcSEcCtD
Methotrexate—Paraesthesia—Betamethasone—psoriatic arthritis	5.21e-05	0.000483	CcSEcCtD
Methotrexate—Discomfort—Prednisone—psoriatic arthritis	5.21e-05	0.000483	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisone—psoriatic arthritis	5.18e-05	0.0239	CbGdCrCtD
Methotrexate—Hypersensitivity—Prednisolone—psoriatic arthritis	5.13e-05	0.000475	CcSEcCtD
Methotrexate—Dyspepsia—Betamethasone—psoriatic arthritis	5.11e-05	0.000474	CcSEcCtD
Methotrexate—Dyspepsia—Dexamethasone—psoriatic arthritis	5.11e-05	0.000474	CcSEcCtD
Methotrexate—Urticaria—Triamcinolone—psoriatic arthritis	5.08e-05	0.000471	CcSEcCtD
Methotrexate—Urticaria—Methylprednisolone—psoriatic arthritis	5.07e-05	0.00047	CcSEcCtD
Methotrexate—Body temperature increased—Triamcinolone—psoriatic arthritis	5.06e-05	0.000469	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisone—psoriatic arthritis	5.06e-05	0.000469	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisolone—psoriatic arthritis	5.05e-05	0.0233	CbGdCrCtD
Methotrexate—Abdominal pain—Methylprednisolone—psoriatic arthritis	5.05e-05	0.000468	CcSEcCtD
Methotrexate—Decreased appetite—Dexamethasone—psoriatic arthritis	5.05e-05	0.000468	CcSEcCtD
Methotrexate—Decreased appetite—Betamethasone—psoriatic arthritis	5.05e-05	0.000468	CcSEcCtD
Methotrexate—Infection—Prednisone—psoriatic arthritis	5.02e-05	0.000466	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	5.01e-05	0.000465	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	5.01e-05	0.000465	CcSEcCtD
Methotrexate—Fatigue—Betamethasone—psoriatic arthritis	5.01e-05	0.000464	CcSEcCtD
Methotrexate—Fatigue—Dexamethasone—psoriatic arthritis	5.01e-05	0.000464	CcSEcCtD
Methotrexate—Pain—Betamethasone—psoriatic arthritis	4.96e-05	0.00046	CcSEcCtD
Methotrexate—Pain—Dexamethasone—psoriatic arthritis	4.96e-05	0.00046	CcSEcCtD
Methotrexate—TYMS—Danazol—Prednisone—psoriatic arthritis	4.96e-05	0.0229	CbGdCrCtD
Methotrexate—Nervous system disorder—Prednisone—psoriatic arthritis	4.96e-05	0.00046	CcSEcCtD
Methotrexate—Skin disorder—Prednisone—psoriatic arthritis	4.91e-05	0.000455	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisone—psoriatic arthritis	4.89e-05	0.000453	CcSEcCtD
Methotrexate—Anorexia—Prednisone—psoriatic arthritis	4.82e-05	0.000447	CcSEcCtD
Methotrexate—Feeling abnormal—Betamethasone—psoriatic arthritis	4.78e-05	0.000443	CcSEcCtD
Methotrexate—Feeling abnormal—Dexamethasone—psoriatic arthritis	4.78e-05	0.000443	CcSEcCtD
Methotrexate—Gastrointestinal pain—Betamethasone—psoriatic arthritis	4.75e-05	0.00044	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	4.75e-05	0.00044	CcSEcCtD
Methotrexate—Hypersensitivity—Triamcinolone—psoriatic arthritis	4.71e-05	0.000437	CcSEcCtD
Methotrexate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	4.7e-05	0.000436	CcSEcCtD
Methotrexate—Urticaria—Betamethasone—psoriatic arthritis	4.61e-05	0.000427	CcSEcCtD
Methotrexate—Urticaria—Dexamethasone—psoriatic arthritis	4.61e-05	0.000427	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	4.61e-05	0.000427	CcSEcCtD
Methotrexate—Dizziness—Prednisolone—psoriatic arthritis	4.6e-05	0.000426	CcSEcCtD
Methotrexate—Asthenia—Triamcinolone—psoriatic arthritis	4.59e-05	0.000426	CcSEcCtD
Methotrexate—Body temperature increased—Dexamethasone—psoriatic arthritis	4.59e-05	0.000425	CcSEcCtD
Methotrexate—Body temperature increased—Betamethasone—psoriatic arthritis	4.59e-05	0.000425	CcSEcCtD
Methotrexate—Abdominal pain—Betamethasone—psoriatic arthritis	4.59e-05	0.000425	CcSEcCtD
Methotrexate—Abdominal pain—Dexamethasone—psoriatic arthritis	4.59e-05	0.000425	CcSEcCtD
Methotrexate—Asthenia—Methylprednisolone—psoriatic arthritis	4.58e-05	0.000425	CcSEcCtD
Methotrexate—Insomnia—Prednisone—psoriatic arthritis	4.57e-05	0.000424	CcSEcCtD
Methotrexate—Paraesthesia—Prednisone—psoriatic arthritis	4.54e-05	0.000421	CcSEcCtD
Methotrexate—Pruritus—Triamcinolone—psoriatic arthritis	4.53e-05	0.00042	CcSEcCtD
Methotrexate—Pruritus—Methylprednisolone—psoriatic arthritis	4.52e-05	0.000419	CcSEcCtD
Methotrexate—Dyspepsia—Prednisone—psoriatic arthritis	4.45e-05	0.000413	CcSEcCtD
Methotrexate—Decreased appetite—Prednisone—psoriatic arthritis	4.39e-05	0.000407	CcSEcCtD
Methotrexate—Rash—Prednisolone—psoriatic arthritis	4.39e-05	0.000407	CcSEcCtD
Methotrexate—Dermatitis—Prednisolone—psoriatic arthritis	4.38e-05	0.000406	CcSEcCtD
Methotrexate—Diarrhoea—Methylprednisolone—psoriatic arthritis	4.37e-05	0.000405	CcSEcCtD
Methotrexate—Fatigue—Prednisone—psoriatic arthritis	4.36e-05	0.000404	CcSEcCtD
Methotrexate—Headache—Prednisolone—psoriatic arthritis	4.36e-05	0.000404	CcSEcCtD
Methotrexate—Dizziness—Triamcinolone—psoriatic arthritis	4.23e-05	0.000392	CcSEcCtD
Methotrexate—Dizziness—Methylprednisolone—psoriatic arthritis	4.22e-05	0.000391	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisone—psoriatic arthritis	4.17e-05	0.000386	CcSEcCtD
Methotrexate—Asthenia—Dexamethasone—psoriatic arthritis	4.17e-05	0.000386	CcSEcCtD
Methotrexate—Asthenia—Betamethasone—psoriatic arthritis	4.17e-05	0.000386	CcSEcCtD
Methotrexate—Gastrointestinal pain—Prednisone—psoriatic arthritis	4.13e-05	0.000383	CcSEcCtD
Methotrexate—Nausea—Prednisolone—psoriatic arthritis	4.13e-05	0.000383	CcSEcCtD
Methotrexate—Pruritus—Dexamethasone—psoriatic arthritis	4.11e-05	0.000381	CcSEcCtD
Methotrexate—Pruritus—Betamethasone—psoriatic arthritis	4.11e-05	0.000381	CcSEcCtD
Methotrexate—Vomiting—Triamcinolone—psoriatic arthritis	4.07e-05	0.000377	CcSEcCtD
Methotrexate—Vomiting—Methylprednisolone—psoriatic arthritis	4.06e-05	0.000376	CcSEcCtD
Methotrexate—Rash—Triamcinolone—psoriatic arthritis	4.03e-05	0.000374	CcSEcCtD
Methotrexate—Dermatitis—Triamcinolone—psoriatic arthritis	4.03e-05	0.000374	CcSEcCtD
Methotrexate—Rash—Methylprednisolone—psoriatic arthritis	4.03e-05	0.000373	CcSEcCtD
Methotrexate—Dermatitis—Methylprednisolone—psoriatic arthritis	4.02e-05	0.000373	CcSEcCtD
Methotrexate—Urticaria—Prednisone—psoriatic arthritis	4.02e-05	0.000372	CcSEcCtD
Methotrexate—Headache—Triamcinolone—psoriatic arthritis	4.01e-05	0.000372	CcSEcCtD
Methotrexate—Headache—Methylprednisolone—psoriatic arthritis	4e-05	0.000371	CcSEcCtD
Methotrexate—Abdominal pain—Prednisone—psoriatic arthritis	4e-05	0.00037	CcSEcCtD
Methotrexate—Body temperature increased—Prednisone—psoriatic arthritis	4e-05	0.00037	CcSEcCtD
Methotrexate—Diarrhoea—Betamethasone—psoriatic arthritis	3.97e-05	0.000368	CcSEcCtD
Methotrexate—Diarrhoea—Dexamethasone—psoriatic arthritis	3.97e-05	0.000368	CcSEcCtD
Methotrexate—Dizziness—Betamethasone—psoriatic arthritis	3.84e-05	0.000356	CcSEcCtD
Methotrexate—Dizziness—Dexamethasone—psoriatic arthritis	3.84e-05	0.000356	CcSEcCtD
Methotrexate—Nausea—Triamcinolone—psoriatic arthritis	3.8e-05	0.000352	CcSEcCtD
Methotrexate—Nausea—Methylprednisolone—psoriatic arthritis	3.79e-05	0.000351	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisone—psoriatic arthritis	3.72e-05	0.000345	CcSEcCtD
Methotrexate—Vomiting—Betamethasone—psoriatic arthritis	3.69e-05	0.000342	CcSEcCtD
Methotrexate—Vomiting—Dexamethasone—psoriatic arthritis	3.69e-05	0.000342	CcSEcCtD
Methotrexate—Rash—Betamethasone—psoriatic arthritis	3.66e-05	0.000339	CcSEcCtD
Methotrexate—Rash—Dexamethasone—psoriatic arthritis	3.66e-05	0.000339	CcSEcCtD
Methotrexate—Dermatitis—Betamethasone—psoriatic arthritis	3.66e-05	0.000339	CcSEcCtD
Methotrexate—Dermatitis—Dexamethasone—psoriatic arthritis	3.66e-05	0.000339	CcSEcCtD
Methotrexate—Headache—Dexamethasone—psoriatic arthritis	3.64e-05	0.000337	CcSEcCtD
Methotrexate—Headache—Betamethasone—psoriatic arthritis	3.64e-05	0.000337	CcSEcCtD
Methotrexate—Asthenia—Prednisone—psoriatic arthritis	3.63e-05	0.000336	CcSEcCtD
Methotrexate—Pruritus—Prednisone—psoriatic arthritis	3.58e-05	0.000332	CcSEcCtD
Methotrexate—Diarrhoea—Prednisone—psoriatic arthritis	3.46e-05	0.000321	CcSEcCtD
Methotrexate—Nausea—Betamethasone—psoriatic arthritis	3.45e-05	0.00032	CcSEcCtD
Methotrexate—Nausea—Dexamethasone—psoriatic arthritis	3.45e-05	0.00032	CcSEcCtD
Methotrexate—Dizziness—Prednisone—psoriatic arthritis	3.34e-05	0.00031	CcSEcCtD
Methotrexate—Vomiting—Prednisone—psoriatic arthritis	3.21e-05	0.000298	CcSEcCtD
Methotrexate—Rash—Prednisone—psoriatic arthritis	3.19e-05	0.000295	CcSEcCtD
Methotrexate—Dermatitis—Prednisone—psoriatic arthritis	3.18e-05	0.000295	CcSEcCtD
Methotrexate—Headache—Prednisone—psoriatic arthritis	3.17e-05	0.000294	CcSEcCtD
Methotrexate—Nausea—Prednisone—psoriatic arthritis	3e-05	0.000278	CcSEcCtD
